Circulating Anti-Helicobacter pylori Immunoglobulin A Antibodies and Low Serum Pepsinogen I Level Are Associated with Increased Risk of Gastric Cancer
Authors:
Open Access
- 15 July 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 144 (2) , 142-149
Abstract
Helicobacter pylori infection has been suggested to be associated with an increased risk of gastric cancer, and low levels of serum pepsinogen I (PG I) have been linked to atrophic gastritis, which is a risk factor for gastric cancer. In Finland, 39,268 persons from 25 cohorts participated during 1968–1972 in a health examination survey and were followed for up to 13 years. A nested case-control study was performed on 84 stomach cancer patients identified from the Finnish Cancer Registry and 146 controls matched for age, sex, and municipality. Serum samples drawn at the baseline study were analyzed. An elevated level of serum anti-H. pylori immunoglobulin A (IgA) antibodies (a titer >70) and a low serum PG I level (IgG) (>700), the odds ratio was only 1.50 (95% Cl 0.70–3.22). When both high IgA and low PG I were present, the odds ratio was 5.96 (95% Cl 2.02–17.57). The association of H. pylori infection with cancer became stronger with longer follow-up times, whereas that of low PG I was strongest at shorter follow-up times. Our findings support the hypothesis that H. pylori infection is a prevalent and potentially preventable cause of gastric cancer. They stress the value of IgA antibody determinations and provide new evidence for a pathogenesis leading from prolonged infection through atrophic gastritis to gastric cancer. Am J Epidemiol 1996; 144: 142–9.Keywords
This publication has 23 references indexed in Scilit:
- High prevalence of neutralizing activity to helicobacter pylori cytotoxin in serum of gastric‐carcinoma patientsInternational Journal of Cancer, 1994
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993
- Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pyloriThe Lancet, 1992
- Helicobacter pyloriInfection and Gastric Carcinoma among Japanese Americans in HawaiiNew England Journal of Medicine, 1991
- Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritisGastroenterology, 1991
- Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural ChinaInternational Journal of Cancer, 1990
- Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopyThe American Journal of Medicine, 1990
- Helicobacter pylori and the Pathogenesis of Gastroduodenal InflammationThe Journal of Infectious Diseases, 1990
- Estimates of the worldwide frequency of sixteen major cancers in 1980International Journal of Cancer, 1988
- SERUM VITAMIN E AND RISK OF CANCER AMONG FINNISH MEN DURING A 10-YEAR FOLLOW-UPAmerican Journal of Epidemiology, 1988